People are filing hair relaxer cancer lawsuits because they or their loved ones developed cancer after being exposed to dangerous chemicals. Many women use hair relaxers as a part of their normal self-care regimen. However, research and diagnoses have shown a possible link between hair-relaxing chemicals and ovarian cancer, uterine cancer and endometrial cancer.
Hair relaxer lawsuits claim defendants:
- Knew or should have known about the risks of hair-relaxing chemicals
- Marketed dangerous products without warning consumers
- Misrepresented the products as “safe” and “natural”
- Reinforced discriminatory standards of beauty and negative stereotypes about afro-textured hair
These lawsuits began after a 2022 study linked chemical hair relaxers to an increased risk of uterine cancer. The 2022 study used data from the National Institute of Environmental Health Sciences (NIEHS). The NIEHS is part of the National Institute of Health (NIH).
Researchers found women who frequently used chemical hair straighteners were more than twice as likely to develop uterine cancer over those who did not. This study used data from a larger body of research called the Sister Study. The Sister Study followed 50,000 women for 10 years to study cancer and what might cause it. Earlier research had linked using these products to an increased risk of ovarian cancer.
People began to file hair relaxer cancer lawsuits shortly after the 2022 NIEHS study. Motley Rice lawyers are currently evaluating potential cases involving these types of cancer:
- Ovarian cancer
- Uterine cancer
- Endometrial cancer
These cancers have been connected with various chemicals present in hair relaxer products.
Is there a hair relaxer class action lawsuit?
A class action and multidistrict litigation (MDL) are currently proceeding in federal court. The MDL consolidates multiple chemical hair straightener lawsuits across the country. The MDL is against hair relaxer manufacturers over the alleged link between the use of hair relaxers and cancer diagnoses.
As of June 3, 2024, 8,270 actions were pending in the hair relaxer MDL.
In 2023, Fidelma Fitzpatrick was appointed co-lead counsel for MDL 3060 In re: Hair Relaxer Marketing Sales Practices And Products Liability Litigation in the Northern District of Illinois. Carmen Scott is co-chair of the Leadership Development Committee for the MDL. Tope Leyimu is on the Leadership Development Committee and is co-chair of the L’Oréal Liability Committee.